openPR Logo
Press release

Global MicroRNA Market to Register a Robust CAGR of 7.9% During the Assessment Period 2017 - 2025

Global MicroRNA Market to Register a Robust CAGR of 7.9% During

Global microRNA market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand of microRNA re-agents and kits for various applications that could eventually translate into developing innovative therapeutic solutions for various difficult-to-treat illnesses. According to the new report published by Persistence Market Research titled, “MicroRNA Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” which tracks the performance of global microRNA market for the period of eight years, i.e. 2017-2025, the global market is projected to register a CAGR of 7.9% in terms of value during the forecast period. The market is anticipated to be valued at US$ 666.7 Mn by 2025.

Global MicroRNA Market: Restraints

Poor reproducibility of research and specificity of products
Complication in vendor selection due to large product portfolios
Requirement of skilled personnel and limited availability of data analysis tools
In-house development of assays for microrna detection
RNA is more challenging to handle
High cost associated with microrna reagents and other similar products
Limited life science research infrastructure in emerging markets

Request Sample Report@ https://www.persistencemarketresearch.com/samples/3464

Global MicroRNA Market: Forecast by Assay Type

On the basis of assay type, the global microRNA market is segmented into PCR-based Assay, miRNA Arrays, Next Generation Sequencing (NGS), and Immunoassay. Immunoassay segment is further segmented into Fluorescent Assays, Colorimetric Assays, and Chemiluminescent Assays. On the basis of assay type, PCR based arrays segment accounted for 34.9% market share in 2016 in terms of revenue, which is expected to increase to 36.9% by 2025 end. Next generation sequencing is expected to be the second largest segment in terms of revenue growth in microRNA market and is expected to register a CAGR of 8.1% over the forecast period.

Global MicroRNA Market: Forecast by Application

On the basis of application, the global microRNA market is segmented into Clinical Diagnostics and Research. Research is the largest segment in global microRNA market, which is estimated to represent US$ 275.7 Mn, or 76.1% share of the total market in 2017 and US$ 525.6 Mn, or 78.8% by 2025 end, expanding at CAGR of 8.4% over the forecast period. Research segment dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Research segment is expected to be the most lucrative among all end users, with attractiveness index of 1.6.

Global MicroRNA Market: Forecast by End User

On the basis of end-user, the global microRNA market is segmented into Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, and Diagnostic Centers. Academic & research institutes end user is the largest segment in global microRNA market, which is estimated to represent US$ 138.9 Mn of the total market in 2017 and is anticipate to be valued at US$ 255.9 Mn by 2025 end, expanding at CAGR of 7.9% over the forecast period. Academic & research institutes dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.

Global MicroRNA Market: Forecast by Region

Five regions have covered in this report such as North America, Latin America, Europe, APAC and MEA. North America is the largest region in microRNA market, which is estimated to represent US$ 140.3 Mn, or 38.7% share of the total market in 2017 and is projected to reach to US$ 245.9 Mn, or 36.9%, expanding at CAGR of 7.3% over the forecast period of 2017–2025. Europe is expected to be the second most lucrative market, with attractiveness index of 1.3 during the forecast period.

Request TOC@ https://www.persistencemarketresearch.com/methodology/3464

Global MicroRNA Market: Key Players

Some of the key players operating in the global microRNA market are Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Bio-Rad Laboratories Inc.,Sigma Aldrich Corp., Qiagen N.V, Thermo Fisher Scientific, Inc., HTG Molecular Diagnostics, Inc., Bioline GmbH (A Meridian Life Science Company), Rosetta Genomics Ltd., Dharmacon, a Horizon Discovery Group Co., BioVendor — Laboratorní medicína a.s., Miltenyi Biotec, Kaneka Corporation (Eurogentec), Abcam Plc, GeneCopoeia, Inc., Promega Corporation, New England Biolabs, Inc., NanoString Technologies, Inc., and System Biosciences LLC.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global MicroRNA Market to Register a Robust CAGR of 7.9% During the Assessment Period 2017 - 2025 here

News-ID: 1182990 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and